Ardelyx Equities

Ardelyx Unveils Additional Clinical Data for IBSRELA® at Digestive Disease Week 2024 May 21, 2024

Ardelyx Showcases Further Evidence of IBSRELA® Efficacy at 2024 Digestive Disease Week May 21, 2024

Ardelyx Sets Date for Update on IBSRELA® and IBS-C Sector Expert Discussion Jan 4, 2024

Ardelyx Announces Upcoming Update on IBSRELA® and Expert Discussion on IBS-C Market Jan 3, 2024